In addition, we found that treatment with a combination of sorafenib and PI3K inhibitors slowed the growth of HCC cells with high expression of FNDC5 and increased the level of ferroptosis (Figures 7D, , E). The gene discussed is FNDC5; the disease is hepatocellular carcinoma.